Few data exist regarding management strategies for women with early treatment failure for bacterial vaginosis. Cure rates after re-treatment were compared for two topical agents. The overall cure rate was 62%; rates between medications were comparable. Re-treatment with the same topical medication for early recurrence is an acceptable strategy.
From the *Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh/Magee-Womens Hospital, Pittsburgh, PA; and †Magee-Womens Research Institute, Pittsburgh, PA.
Supported by an unrestricted research grant from 3M pharmaceuticals and NIH/NIAID U01 AI47785 (CRC MO1 RR00056).
Correspondence: Katherine Bunge, MD, Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Hospital, 300 Halket Street, Pittsburgh, PA 15213. E-mail: email@example.com.
Received for publication February 2, 2009, and accepted May 15, 2009.